Americas Sterility Testing Market Research Report-Forecast till 2030

Americas Sterility Testing Market Research Report: By Product (Instrument, Reagent & Services, Kits and others), Type of Tests (Membrane Filtration Sterility Testing, Direct Incubation Sterility Testing, Direct Transfer and others), By Application (Pharmaceutical & Biological Manufacturing, Medical Devices Manufacturing, other), and By End User (Pharmaceuticals, Hospital and Laboratories and other), – Forecast till 2030

ID: MRFR/LS/0128-HCR | 60 Pages | Published By Rahul Gotadki on March 2023         

Market Scenario: The Americas Sterility Testing Market is expected to reach USD 7,632.3 Million by 2030 at 10.4% CAGR during the forecast period 2022-2030. Sterility testing is one of the important aspect in the healthcare sector. It ensures the purity and safety of a product or a substance. Sterilization of the product and devices ensures the safety of the products. The major driving factor for the growth of the market are increasing manufactures of the medical devices & products, increasing prevalence of many infectious diseases, and increasing in the R&D activities. According to the Centers for Disease Control and Prevention, in 2012, about half of all adults i.e. 117 million American had one or more chronic health problem. Increasing number of diseases has intensified the research activities, which has significantly driven the market. Furthermore, technological advances, growth of pharmaceutical industries, increasing support provided by the government and increasing R&D investment have fuelled the market growth in this region. However, time consuming approval process and strict regulatory guidelines are the key factors responsible for slow the market growth, which is expected to do so over the given period.

Market Assessment Americas Sterility Testing Market-

Source: World Health Organization (WHO, white paper, company presentation, annual report

Intended Audience

  • Product manufacturers of sterility product

  • Sterility testing product distributors

  • Government and private research companies

  • Research and development (R&D) companies

  • Hospitals and laboratories

  • Medical research laboratories

  • Academic medical institutes and universities

Segmentation The Americas sterility testing market is segmented on the basis of products, types of test, application, and end users. On basis of type of product, the market is segmented into instrument, reagent & services, kits, and others. On the basis of type of tests, the market is segmented into membrane filtration sterility testing, direct incubation sterility testing, direct transfer, and others. On the basis of application, the market is segmented into pharmaceutical & biological manufacturing, medical devices manufacturing, and others. On the basis of end user, they are segmented into pharmaceuticals, hospital & laboratories, and other.

 The Americas sterility testing market is expected to grow at a CAGR of 9.8% during the projected period 2017-2023 

Figure 1:- Americas sterility testing market, by products 2016 (% share) Americas Sterility Testing Market

Source: World Health Organization (WHO, white paper, company presentation, annual report Regional Analysis On the regional basis, the Americas is segmented into North America and South America. North America holds a major share of the market owing to increasing number of approval of new drugs, increasing demand for the better quality products and increasing number of healthcare organizations like hospital, private research institute has led to increase in the market in North America. America sterility testing market is segmented into the US and Canada. The US is the major contributor to the market in this region. South America shows a steady growth in the market. Key Players Some of the major player in the market are Charles River Laboratories International, Inc. (US), Avance Biosciences (US), Boston Scientific Corporation (US), Paragon Bioservices, Inc (US), Thermo Fisher Scientific, Inc. (U.S.), Avista Pharma Solutions (US), DYNALABS LLC. (US), and Merck KGaA (Germany)

Speak to Analyst Ask for Customization